Study: COVID-19 vaccine reduces risk of major cardiovascular events by 40%
By
Daniel Wu
Even the toaster can't save this one.
Summary
A new study found that the coronavirus vaccine reduced the risk of major cardiovascular events linked to COVID-19—including strokes, heart attacks, and hospitalizations from heart disease—by approximately 40%. The research adds to growing evidence that these heart health benefits have persisted for years. Researchers also noted the vaccine reduced cardiovascular conditions, hospitalizations, and deaths from all causes, including those not linked to COVID.
Key quotes
· 3 pulledThe coronavirus vaccine reduced the risk of major cardiovascular events linked to covid-19 — strokes, heart attacks, and hospitalization from heart disease — by about 40 percent.
The findings, the latest in a growing body of research about the vaccine's benefits for heart health, suggest such benefits observed in earlier studies have persisted for years.
The vaccine reduced cardiovascular conditions, hospitalizations and deaths of all causes, including those not linked to covid, researchers said.
You might also wanna read
Study Examines Association Between mRNA COVID-19 Vaccination and 4-Year All-Cause Mortality in French Adults Aged 18-59
This cohort study analyzes data from over 28 million French adults aged 18-59 to examine the association between mRNA COVID-19 vaccination a
jamanetwork.com·6mo ago
Shingles Vaccination Reduces Mild Cognitive Impairment and Dementia-Related Deaths, Study Finds
A natural experiment study found that herpes zoster (shingles) vaccination reduces the occurrence of mild cognitive impairment and deaths du
Undisclosed Deaths in the Pfizer mRNA Covid-19 Vaccine Trial [pdf]
Microfluidic Assay Quantifies Fibrinaloid Clots in Pediatric Long COVID Patients
This research article presents a study using microfluidic assays to quantify fibrinaloid clots in plasma from pediatric Long COVID patients.
researchsquare.com·8mo ago
Cardiovascular Disease Prevention Through Pharmaceutical LDL Reduction
The article argues that cardiovascular disease (CVD) is effectively a solved problem due to modern pharmaceutical interventions. It explains
totalhealthoptimization.com·5mo ago
Personalized Vitamin D Supplementation Reduces Heart Attack Risk by 52% in Clinical Trial
A new randomized controlled trial called TARGET-D presented at the American Heart Association Scientific Sessions found that personalized vi
empirical.health·4mo ago